The L-type Ca v 1.2 calcium channel is present throughout the animal kingdom and is essential for some aspects of CNS function, cardiac and smooth muscle contractility, neuroendocrine regulation, and multiple other processes. The L-type Ca V 1.2 channel is built by up to four subunits; all subunits exist in various splice variants that potentially affect the biophysical and biological functions of the channel. Many of the Ca V 1.2 channel properties have been analyzed in heterologous expression systems including regulation of the L-type Ca V 1.2 channel by Ca 2ϩ itself and protein kinases. However, targeted mutations of the calcium channel genes confirmed only some of these in vitro findings. Substitution of the respective serines by alanine showed that ␤-adrenergic upregulation of the cardiac Ca V 1.2 channel did not depend on the phosphorylation of the in vitro specified amino acids. Moreover, well-established in vitro phosphorylation sites of the Ca V ␤ 2 subunit of the cardiac L-type Ca V 1.2 channel were found to be irrelevant for the in vivo regulation of the channel. However, the molecular basis of some kinetic properties, such as Ca 2ϩ -dependent inactivation and facilitation, has been approved by in vivo mutagenesis of the Ca V 1.2␣ 1 gene. This article summarizes recent findings on the in vivo relevance of well-established in vitro results.
I. INTRODUCTION
The voltage-gated L-type calcium channel Ca V 1.2 is an integral cell membrane protein complex that mediates the influx of Ca 2ϩ into the cell in response to membrane depolarization. The entered Ca 2ϩ serves as an essential intracellular messenger that regulates a variety of cellular processes including muscle contraction, hormone secretion, neuronal transmission, and gene expression. These physiological processes depend partially on the activity of the Ca V 1.2 channel and have been characterized as excitation-contraction, excitation-secretion, or excitation-transcription coupling (49, 184, 204).
Voltage-gated calcium channels consist of at least four subunits: the ␣ 1 subunit shapes the Ca 2ϩ selective pore, contains the voltage sensor and the binding sites for most regulatory modulators and drugs, whereas the accessory subunits ␣ 2 ␦, ␤, and ␥ are involved in anchorage, trafficking, and regulatory functions (48, 132, 204) . Ca V 1.2 channels typically require a strong depolarization for activation, show long-lasting activity, and are substantially blocked by low micromolar concentrations of organic L-type calcium channel antagonists including dihydropyridines (DHP), phenylalkylamines, and benzothiazepines (243, 245, 292) . These properties classify the Ca V 1.2 channel as a member of the high voltage-gated, DHP-sensitive, L-type calcium channels. This group contains four members named according to their ␣ 1 subunits Ca V 1.1, Ca V 1.2, Ca V 1.3, and Ca V 1.4 (79) . The other subfamilies of voltage-gated calcium channels, discriminated by their electrophysiological and pharmacological properties, are likewise named according to their ␣ 1 subunits and include Ca V 2.1 (P/Q-type Ca 2ϩ current), Ca V 2.2 (N-type Ca 2ϩ current), Ca V 2.3 (R-type Ca 2ϩ current), and Ca V 3.1-3.3 (T-type Ca 2ϩ current) (79) .
Ca V 1.2 channels are multisubunit protein complexes composed of the three subunits, designated ␣ 1 , ␣ 2 ␦, and ␤ (50, 69, 70, 205) . Ca V 1.1 is additionally associated with the ␥ 1 -subunit. Similarly, N-type Ca 2ϩ channels (195, 309) , P/Q-type Ca 2ϩ channels (190) , and the R-type Ca 2ϩ channels (308) are also built of these three subunits ␣ 1 , ␣ 2 ␦, and ␤. In contrast, T-type channels seem to consist only of an ␣ 1 subunit (226) , since blocking expression of all Ca V ␤ gene products by anti-Ca V ␤ antisense oligonucleotides in ganglion neurons (170) or absence of Ca V ␤1 or Ca V ␥1 (279) did not affect T-type currents.
A depth of information was obtained by electrophysiological, pharmacological, and physiological studies on the distribution and physiological function of the various voltage-gated calcium channels. These experiments were performed mainly in expression systems and isolated tissues and have been extensively reviewed (49, 133, 204) . While the current knowledge about voltage-gated calcium channels is mainly based on these in vitro studies, the physiological characteristics of these channels in native tissue, i.e., in vivo, and the contribution of the channels to broad scope function are revealed only just now. In recent years, the in vivo role and regulation of the Ca V 1.2 channel has been investigated by overexpressing, knocking out, or site-directed mutagenesis of the Ca V 1.2␣ 1 and the Ca V ␤ genes in transgenic mice. This approach confirmed or challenged the established facts regarding Ca 2ϩ channel regulation and the control of Ca 2ϩ -dependent cellular processes. This review provides an overview of properties of Ca V 1.2 channel in expression studies and in studies using subunitspecific mutations of the Ca V 1.2 channel complex in mice. In addition, spontaneously occurring monogenic defects in Ca 2ϩ channel subunit genes will also be covered.
II. STRUCTURE AND SUBUNITS OF THE VOLTAGE-GATED L-TYPE Ca V 1.2 Ca

2؉
CHANNEL
The voltage-gated L-type Ca 2ϩ channels were first purified from skeletal muscle membranes using their extensive binding of radioactive labeled Ca 2ϩ channel blockers of the DHP type (48, 87, 91, 93, 107, 108). The purified DHP receptor complex was built up of five proteins which were named ␣ 1 (ϳ170 -240 kDa), ␣ 2 (ϳ150 kDa), ␤ (ϳ54 kDa), ␦ (17-25 kDa), and ␥ (ϳ32 kDa). Although the ␣ 2 and ␦ proteins were initially described as single subunits, a follow-up study revealed that a single ␣ 2 /␦ mRNA encodes a precursor protein that is proteolysed into the ␦ and ␣ 2 subunits linked by disulfide bonds (63) probably involving Cys404 and Cys1047 (46). Purification of these skeletal muscle proteins allowed the cloning of the respective genes (33, 76, 144, 248, 283) and by homology screening the identification of the other highvoltage-activated Ca 2ϩ channels (for review, see Refs. 48, 70, 133).
Ten mammalian ␣ 1 subunit cDNAs were cloned (TABLE 1). All 10 subunits can be divided into three structurally related subfamilies, namely, Ca V 1, Ca V 2, and Ca V 3 (79) . For the ␣ 2 ␦ subunit, four mammalian genes have been identified which are named cacna2d1, cacna2d2, cacna2d3, and cacna2d4 and encode Ca V ␣ 2 ␦-1, Ca V ␣ 2 ␦-2, Ca V ␣ 2 ␦-3, and Ca V ␣ 2 ␦-4, respectively (59, 162). Likewise, four mammalian genes (cacnb1-4) have been described to encode for the diverse Ca V ␤1-4 subunits (47, 137, 227, 248) . For the ␥ subunit, the first subunit was cloned from skeletal muscle (33, 144). Successively, seven additional genes have been found to code for Ca V ␥ subunits and termed cacng1-8 (42, 52, 161). Only Ca V ␥1 and Ca V ␥6 are considered to be a subunit of a voltage-gated calcium channel (52). Deletion of Ca V ␥1 affected the properties of the skeletal muscle Ca V 1.1 channel (94). The mRNA of Ca V ␥6 has been identified in cardiac muscle. Coexpression of this subunit with Ca V 3.1 in HEK cells increased the expressed current (122). The other subunits, Ca V ␥2, 3, 4, 7, and 8, have been identified as transmembrane AMPA receptor regulatory proteins (TARPs) that affect the trafficking and gating of AMPA receptors (276) . Although a number of studies reported interaction of the other Ca V ␥ subunits with Ca V channels in expression systems (154, 316) , it remains to be shown that these subunits interact with the voltage-gated calcium channel in native tissue.
In recent times, it has become evident that with the exception of the Ca V ␣ 1 subunit, the other auxiliary subunits may associate also with different channels or proteins. The Ca V ␤ 3 subunit has been found to affect proteins not related to voltagegated Ca 2ϩ channels (23, 321) . Several studies have revealed that Ca V ␤ 3 and Ca V ␤ 4 have roles in gene transcription. Ca V ␤ 3 was reported to bind to a novel short splice isoform of the transcription factor PAX6S, which was revealed by a yeast two-hybrid approach (321) . Ca V ␤ 4 acts as a nuclear repressor recruiting platform to control neuronal gene expression in cerebellar Purkinje neurons (280) . The truncated chicken Ca V ␤ 4c subunit interacts directly with a nuclear protein (HP1) (130). The Ca V ␣ 2 ␦ subunits have been reported to be involved in synaptogenesis (78, 167) . The Ca V ␣ 2 ␦-1 and the Ca V ␣ 2 ␦-2 subunits act as receptor for the drugs gabapentin and pregabalin that are used in the therapy of neuropathic pain (103, 110). As stated above, the Ca V ␥2, 3, 4, 7, and 8 subunits mainly act as TARPs (52, 156, 276) .
The Ca V ␣ 1 protein was predicted by hydropathical analysis to consist of four homologous domains (DI-DIV), each composed of six membrane-spanning ␣-helices (termed S1 to S6) that are linked by variable cytoplasmic loops (linkers) and ended by NH 2 -and COOH-terminal intracellular segments, similar to the predicted structure of the voltage-gated Na ϩ and K ϩ channels (73, 283) (see FIGURE 1) . Expression of the Ca V 1.2␣ 1 subunit together with the auxiliary subunits Ca V ␤ 2 and Ca V ␣ 2 ␦ was sufficient to produce functional Ca 2ϩ channels with their characteristic key features such as DHP binding, gating, ion selectivity, and permeation (27, 201, 263) . The human gene for the Ca V 1.2 ␣ 1 subunit is localized at chromosome 12p13 (257) . A structural model of the L-type Ca 2ϩ channel pore has been suggested (274) .
III. SPLICE VARIANTS AND DISTRIBUTION
A. The Ca V 1.2␣ 1 
Channel Subunit
Alternative splicing contributes to both gene regulation and protein diversity. The human Ca V 1.2␣ 1 gene contains 50 exons (FIGURE 1, A AND B) (268) , whereas the Ca V 1.2␣ 1 gene from mouse (181) and rat (305) was reported to miss exon 45, which results in 49 exons. At least 20 exons undergo alternative splicing (1, 54, 268) .
There are at least 13 alternative splicing loci that generate different variants. Alternative splicing occurs in the NH 2 terminus, in the DI-II and DII-DIII linkers, between S5 and S6 in DI, between S2 and S3 in DIV and between S3 and S4 in DIV, in DI-S6, in DII-S2, in DIV-S3, and in the COOH terminus (284) (FIGURE 1). Changes in the expression of the Ca V 1.2␣ 1 subunit have been reported during development of cardiomyocytes (CM), suggesting a differential role of fetal and mature isoforms in juvenile cells (116). Some of these splice variants have been associated with a diversity of biophysical properties: 1) a depolarizing shift of activation for alternatively spliced exons 31 to 33 encoding the DIV S3-S4 region (284) ; 2) faster inactivation kinetics, strong voltage dependence, and variable Ca 2ϩ -dependent inactivation for exon 41 to 42 variants in the COOH terminus (269, 270, 327) ; and 3) a higher DHP sensitivity for exon 8a in DI-S6 (168, 304) . The exclusive alternatively spliced exons 8 and 8a of human cacna1c are mutated in two different types of the Timothy syndrome. Because these exons are mutually exclusive in humans, the effect of a gain-of-function mutation in one exon might be mitigated to some degree by the activity of the alternative wild-type exon in some tissues (273) . The switch from exon 8 to exon 8a-containing Ca V 1.2 mRNAs has been shown to be controlled by the polypyrimidine tract-binding protein (PTB) and its neuronal homolog (nPTB) (286) and to be repressed during neuronal development in mouse brain (286) . Exon 9 contains the binding domain for Ca V ␤-subunits, whereas the adjacent exon 9A (FIGURE 1 ), if present, affects channel gating (180) probably by differentially modulating the interaction with Ca V ␤ isoforms (220, 275) . Exon 9A, sometimes called exon 9*, is not an extension of exon 9 or alternatively used for exon 9 but an exon in its own right (285, 290) . Fox proteins, another family of splicing factors implicated in the control of alternative splicing during development, were recently shown to repress exon 9A and promote inclusion of exon 33 into Ca V 1.2␣ 1 mRNAs expressed in the cortex (287) . 4) Three NH 2 termini have been reported for Ca V 1.2␣ 1 (28, 54, 201) (see FIGURE 2, A -C). Exon 1a (the long NH 2 terminus) is expressed in cardiac myocytes (201) ; exon 1b (the short NH 2 terminus) is expressed in smooth muscle and brain (27, 267, 304) ; and exon 1c (even shorter than exon 1b) is present in resistance cerebral artery (54). The 1b and the 1c isoforms have been detected in arterial smooth muscle from rat and human by Western blot analysis (15). The "smooth muscle" splice variant Ca V 1.2b (28) is more sensitive to inhibition by DHPs than the heart variant Ca V 1.2a, because it contains the DHP-sensitive exon 8B (304) . In vitro and in vivo studies suggest that the Ca V 1.2 channel containing exon 1b or 1c is better expressed than the channel containing exon 1a (67, 71, 95, 304) . The reason for this difference is presently unknown. Exon 1a is crucial for protein kinase C (PKC)-dependent upregulation of the cardiac Ca V 1.2 current, although this sequence is not phosphorylated by PKC (31).
The relative abundance of Ca V 1.2␣ 1 splice variants shows disease-specific variability (297) . The splice variant containing exon 31 is more abundant in normal human hearts, whereas a splice variant with a switch to the exon 32 variant was found in failing hearts (297) . An increase in the number of nonfunctional Ca V 1.2␣ 1 splice variants was found in hearts from spontaneously hypertensive rats compared with normotensive Wistar-Kyoto rats (285) . An isoform with preferential deletion of exon 9A and inclusion of exon 33 has been observed in rats with myocardial infarction (179) . The wild-type isoform Delta9A/33 (deletion of exon 9A and inclusion of exon 33) channel was reduced greatly in the scar region. A novel isoform 9A/Delta33 (inclusion of exon 9A and deletion of exon 33) channel was detected in the scar region (179). As noted above, exon 9A/(synonymous 9*) follows exon 9 and is an independent additional exon not related to 9. In contrast, exon 33* is still exon 33, but differentially spliced resulting in elongation of the common amino acid sequence encoded by exon 33. 1 7 * 1 8 1 9 2 0 2 1 2 2 2 3 2 4 2 5 2 6 2 7 2 8 2 9 3 0 3 1 3 2 3 3 3 3 * 3 4 3 5 3 6 3 7 3 8 3 9 4 0 4 1 4 2 4 3 4 4 4 6 4 7 4 8 4 9 in hypertensive rat hearts (285) . At present, we do not know whether or not the detected Ca V 1.2␣ 1 splicing variants are disease specifically regulated or represent just individual splice variations. It is also possible that some splice variations are related to the change from adult to fetal gene expression program observed in cardiac remodeling (106).
The four members of the L-type Ca 2ϩ channels, namely, Ca V 1.1 to Ca V 1.4, have a distinct tissue distribution. Ca V 1.1 has been found exclusively in skeletal muscle, but a report suggested that human Ca V 1.1 was also coexpressed with ryanodine receptors (RYRs) in GABAergic neurons (281) . Ca V 1.2 is expressed in various tissues including heart (32, 50, 314), smooth muscle (131, 206), pancreas (256) , adrenal gland, and brain (124). The Ca V 1.2 channel has been assumed to be the major L-type channel involved in cardiac excitationcontraction coupling. Ca V 1.3 is mainly found in brain, albeit at lower levels than Ca V 1.2 (124), but also in pancreas, kidney, ovary, and cochlea. Ca V 1.3 transcripts have also been detected in the sinoatrial node (32, 234) and in both atria and ventricles at fetal and neonatal stages but not in adult ventricles (241) . Ca V 1.4 expression seems so far to be restricted to the retina (20).
B. The Ca V ␣ 2 ␦ Channel Subunit
Several splice variants of the Ca V ␣ 2 ␦ channel subunit have been reported. The subunit found in rat skeletal muscle has been described to differ from that found in rat brain containing an insertion of 7 amino acid residues and a deletion of a 19-amino acid segment between putative transmembrane domains 1 and 2 (158) . Subsequent analysis in the mouse revealed the presence of at least five different isoforms that arose from various combinations of three alternatively spliced regions (7). Different combinations of these alternatively spliced regions were found in mouse brain and skeletal muscle, whereas all five isoforms were reported to be present in the cardiovascular system (7). A number of splice variants of the human Ca V ␣ 2 ␦-2 and Ca V ␣ 2 ␦-4 subunit have been also described (17, 240). However, up to now, it is not known whether the different splice variants contribute to different properties of native Ca V 1.2 channels (for review, see Refs. 7, 69, 162) . Recently, a gene-disrupting mutation in cacna2d3 (Ca V ␣ 2 ␦-3) was found in an exome sequencing study on families with children affected by autism spectrum disorders (142). FIGURE 1) ; the 1C sequence has been identified in rats (see FIGURE 1), and the mouse sequence shown is predicted based on its similarity with the rat sequence.
C. The Ca V ␤ Channel Subunit
The amino acid sequences of the Cav␤ subunits are encoded by four genes and differ considerably. The differences are located within their NH 2 termini (called the variable region 1 or V1), within the linker between their SH3 domains and GK domains (variable region 2 or V2) and within their COOH termini (V3), whereas their SH3 and GK domains are very similar (39, 75). The Ca V 1.2␣ 1 subunit most probably is associated with either the Ca V ␤ 2 or the Ca V ␤ 3 subunit (181, 183, 216) and in brain also with the Ca V ␤ 4 subunit (183, 230) . Only a single variant of the Ca V ␤ 3 subunit has been reported to be present in human myocardium (136). Splicing of the 5' exons of the Ca V ␤ 2 gene results in at least five variants of the Ca V ␤ 2 subunit that differ in the NH 2 terminus (FIGURE 3). The Ca V ␤ 2 cDNA was detected by two groups that screened heart and brain libraries (137, 227) but identified two different splice variants; both were called Ca V ␤ 2a . The brain Ca V ␤ 2a subunit (Ca V ␤ 2 -N3, see FIGURE 3 for nomenclature and NH 2 terminus) contains two cysteine residues at positions 3 and 4 that are palmitoylated (239) . This splice variation confers distinguishing features to the Ca V 1.2␣ 1 subunit (239) and has not been found in rabbit, rat, or murine heart (57, 136, 181, 239). Because knockouts of single Ca V ␤ 2 splice variants are not available, the delineation of specific functions to Cavb2-N3 or of other Cavb2 splice variants in vivo remains to be shown. The major splice variant expressed in adult heart and originally also called Ca V ␤ 2a is Ca V ␤ 2 -N4 (FIGURE 3). We suggest renaming the Ca V ␤ 2 subunits according to the expressed NH 2 terminus (FIGURE 3), because that will prevent further confusion on the used Ca V ␤ 2 subunit. a) According to prediction of the human cacn2b gene on chromosome 10 (57) b) Shown not to be present in rat (57, 227) and rabbit heart (137, 239) c) 34 from 60 independent full-length Cavβ 2 cDNA clones from a mouse cardiac cDNA library (181) (181) human heart (92) human heart (128) rat brain (57, 227) rat heart (57, 227) rabbit heart 
IV. ELECTROPHYSIOLOGY OF L-TYPE Ca
2؉ CHANNELS IN HETEROLOGOUS EXPRESSION SYSTEMS
Initial experiments showed that the cardiac Ca V 1.2 ␣ 1 cDNA could be functionally expressed in Xenopus oocytes (201 -dependent inactivation (CDI) and facilitation (CDF).
The Ca V ␣ 2 ␦, Ca V ␤, and Ca V ␥ 1 subunits have pronounced effects on the characteristics of Ca V 1.2 currents. For example, coexpression of the Ca V ␣ 2 /␦ and Ca V ␤ subunits enhanced the amplitude of the current in Xenopus oocytes (263) . Potentiation of Ca V 1.2 currents by a DHP agonist was differentially modulated by the Ca V ␣ 2 /␦ and Ca V ␤ subunits. The combined expression of Ca V 1.2 ␣ 1, Ca V ␣ 2 /␦, and Ca V ␤ was the least sensitive combination (263) . Furthermore, VDA and VDI was accelerated and delayed by Ca V ␣ 2 /␦ and Ca V ␤, respectively (263) . From these findings, it seems that single subunits modulate specific functions of Ca V 1.2 currents, whereas other properties of the current appear to be modulated by the different subunits acting in concert (39, 263). Coexpression of the Ca V ␣ 2 ␦-1 and Ca V ␤ subunits increased I Ba,L most likely by facilitating transfer from the Golgi apparatus to the membrane (69) . VDA is mediated by membrane depolarization that shifts the four S4 segments ("the voltage sensor") of DI through DIV within the membrane and opens the channel gate at the inner side of the membrane (25). Experiments with chimeras between Ca V 1.2 and Ca V 1.1 channels revealed that the DI-S3 segment and the linker connecting DI-S3 and DI-S4 is responsible for the fast VDA of Ca V 1.2 channels (214, 282) . Other molecular determinants of VDA include 1) the external pore and the ion selectivity filter of Ca V 1 channels (166, 251, 315) , 2) the inner pore of Ca V 1 channels (322), and 3) the activation gate (312) . Activation of Ca V 1.2 channel currents using Ba 2ϩ as the charge carrier results in inward Ba 2ϩ currents that activate rapidly and inactivate slowly revealing VDI (193) . In CMs, VDI with Ba 2ϩ as the charge carrier could be obtained more clearly if longer depolarization pulses were applied (i.e., Ͼ2 s) (192, 197) . The molecular determinants of VDI include the cytosolic ends of the S6 segments, the I-II linker, considered to be the inactivation gate, and the NH 2 and COOH termini of Ca V 1 (for review, see Refs. 127, 275). Interestingly, a single point mutation (F1126E) eliminated the permeation and gating differences between Ca 2ϩ and Ba 2ϩ resulting in a Ca 2ϩ -like current in the presence of Ba 2ϩ which supports the idea of interaction between ion occupancy in the outer vestibule of the Ca V 1.2 channel pore and calcium channel gating (178, 261) . However, it should be kept in mind that Ba 2ϩ has been considered as a weak agonist for CDI, because Ba 2ϩ itself was reported to induce CDI (85) and permeation of Na ϩ through Ca V 1.2 channels decreased further the VDI time constant (222) .
VDI is further affected by the Ca V ␤ subunit. The Ca V ␤ subunit interacts at the Ca V 1.2 ␣ 1 subunit with a conserved 18-amino acid section present in the DI-DII intracellular loop. This side has been named AID (␣ 1 interacting domain) (236) . Crystallographic studies have shown that the AID ␣-helix binds to the hydrophobic groove present in the Ca V ␤ subunit GuK (guanylate kinase) domain (53, 223, 295) . Binding of the Ca V ␤ subunit to AID induced a conformational change in the DIS6 and the DI-DII linker that modifies VDA and VDI. The DI-DII linker is suggested to be the particle that occludes the channel pore during inactivation under VDI and CDI conditions (3, 39, 159). Alternative mechanisms for VDI include the participation of the Ca V ␤ subunit and/or the NH 2 and COOH terminus of Cav1.2 ␣ 1 (reviewed in Ref. 275) . CDI is a Ca 2ϩ -triggered inactivation process that requires an intact ␣ 1C COOH terminus IQ domain (327) . The IQ domain binds Ca 2ϩ -CaM and is the critical sequence for CDI (229, 325) . Mutation of the isoleucine in the IQ motif lowers the affinity for Ca 2ϩ -CaM and abolishes CDI (232, 326) . The same region is involved in CDF (325) . CDF requires also Ca 2ϩ /calmodulin kinase II (CaMKII) (74) and phosphorylation of residues in the Ca V 1.2 ␣ 1 (175) or the Ca V ␤ subunit sequence (113).
V. REGULATION OF THE CARDIAC Ca V 1.2 CHANNEL COMPLEX IN EXPRESSION SYSTEMS AND IN VIVO
L-type Ca 2ϩ channels are regulated by a change in membrane potential. Their activity is modulated further by hormones. Reuter (244) showed early that the positive inotropic effect of norepinephrine on the heart muscle increased the cardiac I Ca,L . Later, it was then confirmed that norepinephrine binding to the ␤-adrenergic receptor increased intracellular cAMP levels and activated cAMP-dependent protein kinase (PKA). Elegant experiments showed that the catalytic subunit of PKA increased the duration of the action potential plateau (224) and I Ca,L (151) in guinea pig cardiomyocytes. Ten years later, it was reported that cGMP and cGMP-dependent protein kinase (PKG) decreased cardiac L-type current (199) . However, later experiments suggested that NO/cGMP affects multiple cardiac ion channels by different mechanisms (reviewed in Ref. 89). The mechanism(s) by which PKG modulates cardiac Ca V 1.2 channels remains to be established.
These results stimulated a number of laboratories to unravel the phosphorylation mechanism by expressing the channel in various cultured cells. These in vitro studies suggested that PKA can phosphorylate the Ca V 1.2␣ 1 and Ca V ␤ subunit. For example, the Ca V 1.2␣ 1 and Ca V ␤ 2 -N3 subunits expressed in SF9 cells were phosphorylated by purified PKA and PKC in vitro (237) . PKA phosphorylated the Ca V 1.2 ␣ 1 and the Ca V ␤ 2 -N3 subunit independent of each other. Adrenergic stimulation of intact canine myocardium led to PKA-mediated phosphorylation of the Ca V ␤-subunit, whereas no phosphorylation of the Ca V 1.2␣ 1 subunit was detected (114). These early studies were disputed by the finding that a part of the in vitro isolated ␣ 1 subunits was proteolytically cleaved thereby removing a significant part of the COOH-terminal tail (51, 64, 125, 169, 319) . PKA-induced phosphorylation was observed with the purified full-length 250-kDa form of the Ca V 1.2␣ 1 subunit but not in the truncated 200-kDa form (319). This finding was confirmed when it was reported that Ser 1928 located at the COOH-terminal tail was in vitro a major site of PKA-induced phosphorylation (62, 101, 118, 125, 139, 202, 225) . In addition, Ser 1627 and Ser 1700 have been detected as PKA site in partially purified, truncated bovine cardiac Ca Unfortunately, these initial successful reports (38, 101, 115, 259) were not repeated by other laboratories (200, 323) . A variety of explanations have been offered to explain these differences including the importance of the correct isoform of auxiliary subunits and the need for targeting PKA to the channel by AKAPs (101). These inconsistencies may be also related to differences in the expression systems used, differences in the isoforms used for expression, and differences in the accessory proteins coexpressed with the Ca V 1.2␣ 1 subunit. Xenopus oocytes have endogenous Ca V ␤s that influence exogenously expressed Ca V ␣ 1 (288) . In addition, other enzymes such as protein phosphatases may modify the basal levels of phosphorylation of the channel (157) . This view comes from the findings that inhibitors of PKA decreased channel activity in expression systems, suggesting that the Ca V 1.2␣ 1 channels were already endogenously phosphorylated in these systems without stimulation (225, 228, 262) .
In recent years, this analysis was refined by the use of mice carrying mutations in the Ca V 1.2 channel complex. The Ca V ␤ 2 subunit is phosphorylated in vitro by various protein kinases (105) and may be crucial for adrenergic upregulation of I Ca,L (38, 115). Truncation of the murine Ca V ␤ 2 gene at Pro 501 removes all predicted phosphorylation sites for PKA, PKG, and CaMKII (35). The generated mouse is viable and the ␤-adrenergic stimulation of I Ca,L was preserved in the intact animal and in the isolated cardiomyocytes (35). These results do not support a fundamental role for phosphorylation of the cardiac Ca V ␤ 2 subunit in the fight-or-flight regulation (see also TABLE 2). However, two additional residues are present that are predicted to be phosphorylated by PKA, Ser 143 and Thr 165 (in Ca V ␤ 2 -N4). Interestingly, the Ser 143 residue corresponds to the Ser 182 in rabbit Ca V ␤1a, which has been shown to be phosphorylated in vivo (248) .
As an alternative to the Ca V ␤ 2 subunit, phosphorylation of Ser 1928 in the COOH terminus of the Ca V 1.2 ␣ 1 subunit was widely accepted as a mechanism for the upregulation of I Ca,L (58, 119, 139, 152). However, mutation of Ser 1928 to Ala in the mouse generated viable animals with an unaltered fightor-flight reaction (176) . Expression of a Ca V 1.2␣ 1 subunit with a Ser1928Ala mutation in TsA-201 cells did not affect the adrenergic upregulation of the I Ba,L (98). Adenoviral expression of a Ca V 1.2 channel expressing the Ser 1928 Ala mutation in guinea pig CMs did not abolish ␤-adrenergic regulation of the expressed channel (100). Additional attempts to support the importance of Ser 1928 phosphorylation were unsuccessful. Truncation of the Ca V 1.2 ␣ 1 gene at Asp 1904 (71) or at Gly 1796 (95) removed the COOH-terminal part of the COOH terminus, but resulted in mice that died during or after birth. Further analysis suggested that the truncation of the Ca V 1.2a splice variant prevented insertion of the channel in the membrane, because the truncated protein was directed to the proteasome (71) . In contrast, the Ca V 1.2b channel was normally expressed in non-CM cells, but not in the CMs (67, 71) . Together, these results did not support the hypothesis that phosphorylation of Ser 1928 mediates the ␤-adrenergic upregulation of I Ca,L in the mouse heart. Several groups suggested that reconstitution of the ␤-adrenergic upregulation of I Ca,L required the presence of a PKA anchoring protein (AKAP) (101, 148). AKAPs are a family of proteins that bind PKA regulatory subunit and phosphatases and locate them to specific sites (258 -binding EF hand motif in the COOH terminus was not involved in this process (221, 238) . CaM binding requires isoleucine 1624 of the IQ motif. The mutation I1624E decreased the affinity of the IQ sequence for CaM ϳ100-fold and abrogated CDI of L-type Ca 2ϩ channels expressed in Xenopus oocytes (325, 326) . Likewise, the mutation I1624A abolished CDI of Ca V 1.2 channels expressed in oocytes (325) , whereas the mutated I1624A Ca V 1.2 channels expressed in HEK cells showed essentially normal CDI but an attenuated VDI (18).
Mutation of isoleucine 1624 to glutamate of the murine Ca V 1.2 gene is embryonic lethal (235) . Mice with a conditional heart-specific I/E mutation in the Ca V 1.2␣ 1 channel died within 3 wk after activation of the Cre recombinase, because this mutation prevents membrane incorporation of adequate amounts of Ca V 1.2␣ 1 protein. Further analysis indicated that these mice develop dilated cardiomyopathy (DCM) accompanied by apoptosis of cardiac myocytes and fibrosis (29). Treatment with metoprolol and captopril reduced DCM at day 10. However, cellular contractility and global Ca 2ϩ transients remained unchanged in isolated CMs (29). Electrophysiological analysis at day 10 after Cre induction revealed that the I/E mutation blocks CaM -mediated regulation of the Ca V 1.2 channel in the heart and induces a channel phenotype with permanent CDI characteristics (235) . One explanation for this phenomenon may be that the introduction of the charged glutamate into the IQ motif may mimic the presence of the naturally occurring charged Ca 2ϩ /CaM complex with respect to protein folding during channel gating. In contrast to CDF, it is not clear whether or not CDI requires an active CaMKII (see below).
VII. VOLTAGE-AND Ca
2؉ -DEPENDENT FACILITATION
Voltage-dependent facilitation (VDF) of Ca V 1.2 channels has been observed in native CMs and represents an increase in current amplitude after the respective stimulation. VDF can be observed during repetitive channel activation, i.e., frequencydependent VDF (174), or after a strong prepulse to positive potentials, i.e., VDF (219) . At the single-channel level, mode 2 gating (long openings) were shown to be strongly promoted following large depolarization (231) . VDF is also observed if Ca V 1.2 subunits are expressed in heterologous expression systems (160, 259) but attenuated in Xenopus oocytes by coexpression of the Ca V ␣ 2 ␦ subunit (233) and not observed with Ca V 2 subunits expressed in Xenopus oocytes (4, 34). VDF is abolished by replacement of Ca 2ϩ by Ba 2ϩ (82) and blocked by the fast Ca 2ϩ buffer BAPTA but not the slower EGTA (134), indicating that this process is mediated by Ca 2ϩ entry itself then by a change in the membrane potential. Thus it is likely that VDF represents a CDF. In Xenopus oocytes, CDF of Ca V 1.2␣ 1 was reduced by disruption of the IS6-AID linker and loss of Ca V ␤ binding supporting a requirement of Ca V ␤ binding to the AID and an intact IS6-AID ␣-helix for CDF (88). Overall, facilitation of Ca V 1.2 channels is likely to involve multiple processes including the voltage protocol, the amount of Ca 2ϩ entry, the Ca V ␤ association, and phosphorylation (4, 259).
CDF serves to potentiate Ca 2ϩ influx through Ca V 1.2 channels during repeated activity which contributes to increased force-frequency relationship of the heart muscle during exercise (186, 247) . CaM is required for CDF. CDF is blocked by Ca 2ϩ -insensitive CaM or by inhibition of CaMKII (229, 294, 325, 326) . Single amino acid mutation of the IQ motif (I/E) abrogated CDF of Ca V 1.2 expressed in Xenopus oocytes (326) . CMs from I/E mice lacked CDF (235) . Facilitation was completely abolished by dialysis with either of two inhibitory peptides of CaMKII (320) . Internal dialysis of rabbit myocytes with synthetic inhibitory peptides derived from the pseudosubstrate peptide (amino acids and CaM binding peptide (amino acids 291-317) sequence blocked enhancement of Ca V 1.2 currents (6). CDF was also reduced in mice deficient in CaMKII␦, which indicates that inhibition of physiological CaMKII activity in CMs may significantly affect Ca 2ϩ influx at fast heart rates by reduction of CDF (313) .
CaMKII induces a channel-gating mode that is characterized by frequent, long openings of L-type Ca 2ϩ channels (74) . The Ca V 1.2␣ 1 and the Ca V ␤2 subunit are substrates for CaMKII (2, 113, 135, 175). Ca V 1.2␣ 1 was shown to be phosphorylated at S1512 and S1570 by coexpression of CaMKII in HEK 293 cells (175) . CaMKII was further shown to bind to the Ca V ␤2-N3 subunit and preferentially to phosphorylate Thr 498 (113). Viral-induced overexpression of the mutated Ca V ␤2-N3 subunit (T498A) ablated CaMKII-mediated CDF in adult rat CMs (113) and rabbit (163) . In contrast, CDF was still observed in HEK 293 cells coexpressing a truncated Ca V 1.2␣ 1 subunit and the Ca V ␤2-N4 subunit with a mutation of this putative phosphorylation site (T500A) (175) .
The in vivo significance of the proposed CaMKII phosphorylation sites for CDF was examined in two mouse models (30, 35). In one model (SF mice), S1512 and S1570 of the Ca V 1.2␣ 1 subunit were mutated to alanine (30). CDF was reduced in CMs from SF mice in a CaMKII-dependent manner. In agreement with the anticipated effect of CDF, i.e., prolongation of the plateau phase of the action potential at high frequency (186), QT time was reduced at high frequency (30). However, CDF was not completely abolished, suggesting that an additional mechanism may be required for CDF. This mechanism requires the IQ motif, because the I/E mutated channel did not show CDF anymore (235) . It is possible that the second mechanism requires inactive CaMKII as suggested for Ca V 2.1 channels in adult rat hippocampal pyramidal neurons which may be modulated solely by binding of CaMKII 
VIII. MUTATION IN GENES CODING FOR VOLTAGE-GATED Ca V 1.2 Ca
2؉
CHANNELS
The analysis of human diseases has identified mutations in voltage-gated Ca 2ϩ channels as cause of incomplete X-linked congenital night blindness (Ca V 1.4), familial hemiplegic migraine (Ca V 2.1), ataxia disorders (Ca V 2.1), various murine disorders (Ca V 2.1, ␣ 2 ␦, ␤, and ␥ 2 subunits), and epilepsy susceptibility (Ca V 3.2) (reviewed in Refs. 26, 182, 277). Mutation of the Ca V 1.2 ␣ 1 subunit has been associated with the Timothy syndrome, the Brugada syndrome 3, and early repolarization syndrome (reviewed in Ref. 217 ). Timothy syndrome has been associated with the mutation G406R in exon 8A of the Ca V 1.2 gene (273) . Macroscopic analyses of Ca V 1.2 channels carrying Timothy syndrome mutations (G406R) revealed a delayed CDI resulting in sustained depolarization (18, 272, 273). Homo-and heterozygous mice with a G406R mutation did not survive, whereas heterozygous G406R mice with an inverted neomycin cassette in exon 8A showed distinct behavioral abnormalities, in line with the core aspects of autism and autism spectrum disorders (10). The neomycin cassette left in exon 8A was supposed to reduce expression of mutant exon 8, most likely by transcriptional interference. Interestingly, oligomerization of wild-type Ca V 1.2 channels with G406R Ca V 1.2 channels was shown to increase Ca 2ϩ currents and the frequency of arrhythmogenic Ca 2ϩ fluctuations in transfected rat ventricular myocytes (68) . The latter findings support the hypothesis that functional Ca V 1.2 channels are clustered and open in a cooperative manner (65) .
Brugada syndrome has been associated with a loss-of-function missense mutations in either the Ca V 1.2␣ 1 gene (A39V and G490R, Brugada syndrome-3) or in the N4 encoding exon of the Ca V ␤ 2 gene (S481L, Brugada syndrome-4) (8, 96). Recently, also mutations in the Ca V ␣ 2 ␦ 1 gene have been reported in some Brugada patients (40). All these mutations have been correlated with shorter QT intervals leading to sudden cardiac death.
A polymorphism rs4765913 in the cacna1c (Ca V 1.2 ␣ 1 ) gene is strongly associated with familial bipolar disorder including an increased risk for schizophrenia (86, 121, 265). Interestingly, mice with a reduced neuronal expression of the Ca V 1.2 ␣ 1 protein show a reduced depressive behavior (150), supporting the human findings. Furthermore, observational fear learning is reduced after deletion of the Ca V 1.2 gene in the murine nucleus anterior cingulate cortex (145). The Ca V ␤ 4 protein is highly expressed in the cerebellar Purkinje cells and acts as a repressor recruiting platform to control neuronal gene expression (280) . Ca V ␤ 4 appears to be associated most likely with the Ca V 2.1 channel. The lethargic mouse (lh/lh) has a four-nucleotide insertion into a splice donor site of the Ca V ␤ 4 gene leading to frameshift and a truncated protein with loss of the Ca V ␣ 1 -binding site (43). Neither full-length nor truncated Ca V ␤ 4 protein is expressed in lh/lh mice (194) . This lethargic mutation induces ataxia, focal motor seizures, and cortical spike wave epilepsy and defective cell-mediated immune responses. However, unaltered P-type currents in dissociated lethargic Purkinje neurons indicate that these Ca V 2.1␣ 1A -containing channels retain regulation by other Ca V ␤ subunits (41). In the cochlear hair cell, the Ca V ␤ 4 subunit associates most likely with the Ca V 1.3 channel (165) . Deletion decreases peak I Ca,L . The Ca V ␤ 3 prevails in the cochlear outer hair cells and associates there with the Ca V 1.3 channel. Again, its deletion decreases peak I Ca,L (165) .
IX. Ca V 1.2 AND THE BRAIN
Neurotransmitter release, neuronal excitability and plasticity, excitation-transcription coupling, synaptogenesis, and dendritic growth are regulated by Ca 2ϩ influx via voltagedependent Ca 2ϩ channels. LTP-induced changes probably serve as cellular mechanism for learning and memory (153, 187, 191) . Critical for the induction and maintenance of hippocampal LTP is a rise of the postsynaptic cytosolic Ca 2ϩ concentration (22, 187, 324) usually caused by the opening of NMDA receptor, a receptor-triggered Ca 2ϩ channel. Ca V 1.2 channels were reported to be present on the nerve soma and pre-and postsynaptic in rat hippocampus (289) . CNS neurons express two L-type channels, the Ca V 1.2 and the Ca V 1.3 (129). A comprehensive Ca V channel expression profile of mouse brain and cultured hippocampal neurons has recently been presented (253) . The Ca V 1.3 and Ca V 1.2 channels are necessary to mediate cocaine-induced GluA1 trafficking in the nucleus accumbens (252) . Neuronal Ca V 1.2 activity affects not only intracellular trafficking but inhibits axon growth in DRG neurons (77) .
Hippocampus and neocortex-specific deletion of the cacna1C gene (Ca V 1.2 ␣ 1 ) induced a defect in long LTP, spatial learning, and induction of nuclear gene transcription (203) , whereas deletion of the Ca V 1.3 gene was without effect on these parameters (55). In very elegant work, it was shown that Ca 2ϩ flowing through activated postsynaptic Ca V 1.2 channels regulated the phosphorylation of CREB (306) . Surprisingly, Ca V 2.1 channels were ϳ10-fold less effective in signaling to the nucleus than were Ca V 1.2 channels for the same bulk [Ca 2ϩ ] i increase.
Conditioned fear responses are a popular paradigm to study associative learning and anxiety disorders. Amygdalae express both L-type calcium channels (129). Early studies used L-type Ca 2ϩ channel blockers to show that consolidation and extinction depended on the activity of L-type Ca 2ϩ channels (19, 44, 45, 296). These studies were limited, because the compounds inhibited several distinct Ca V 1 channels and produced a protracted stress response (44, 296). Two groups used neuron specific deletion of the cacna1 gene to delineate the potential importance of Ca V 1.2 for fear consolidation and extinction. It was reported that deletion of Ca V 1.2 did not affect these parameters (196) . However, this negative result was most likely caused by an upregulation of the GluR1 receptor that allows postsynaptic Ca 2ϩ influx as shown in an elegant study by Langwieser et al. (171) . McKinney et al. (196) did not investigate if the deletion of Ca V 1.2 induced the upregulation of other proteins involved in synaptic Ca 2ϩ homeostasis. Langwieser et al. (171) showed that impairment of the Ca V 1.2 channel decreased fear acquisition. Direct injection of verapamil or nifedipine in the basolateral nucleus of the amygdale indicated that the L-type calcium channel blockers interfered with extinction memory (61) . These latter experiments prevented the stress response, but did not distinguish between Ca V 1.3 and Ca V 1.2 channels. On the other hand, forebrain-specific deletion of the Ca V 1.2␣ 1 subunit gene increased fear behavior as measured by the time spent in an open arm (173) .
X. Ca V 1.2 AND SMOOTH MUSCLE
Smooth muscle (SM) is widely distributed in the organism and is the major constituent of blood vessels, intestines, urinary bladder, penis, and uterus. They show a great diversity with respect to embryological, anatomic, or physiological belongings (90). SM can be separated into phasic versus tonic contracting SM. Phasic SM are predominantly present in the gastrointestinal systems and characterized by rhythmic contractile activity. Tonic SMs mainly exist in large arteries and build up the myogenic tone which represents a long-lasting contraction. Blood vessels exhibit both phasic and tonic contractions. For example, portal venous smooth muscle is regarded as a prototypical phasic SM (9), whereas small arteries exhibit a mixture of tonic contractions and phasic contractile activity (reviewed in Ref. 117). The most important task of SM is to contract in response to physiological needs. Contractile force is mainly determined by the amount of phosphorylated myosin light chain (MLC), which is regulated by the balance between the activities of the MLC kinase (MLCK) and the myosin phosphatase (MLCP) (211, 250, 271) . Contraction of SM can be initiated in two distinct ways: 1) increasing [Ca 2ϩ ] i through increased Ca 2ϩ influx or Ca 2ϩ release from the endoplasmatic reticulum thereby activating MLCK, or 2) activation of second messenger systems that inhibit MLCP activity thereby sensitizing the myofilaments to calcium activation. Ca 2ϩ influx through L-type Ca 2ϩ channels has been accepted to be the major source for the increase in [Ca 2ϩ ] i leading to contraction. Ca V 1.2 channels play a particularly important role in smooth muscle reactivity and tone at least in the microcirculation (60) . The important role of the SM Ca V 1.2 channel is generally accepted. High blood pressure is successfully treated with DHPs that inhibit SM Ca V 1.2 channels.
The major form of Ca V 1.2␣ 1 subunit in smooth muscle is the Ca V 1.2b isoform (28) (see also sect. IIIA). The importance of the Ca V 1.2 channel for smooth muscle function has been revealed in a mouse model, in which the Ca V 1.2␣ 1 subunit was selectively deleted in smooth muscle (206) using a Cre/lox site specific recombination system (164) . These mice died within 21 days after Cre activation due to a paralytic ileus (298) . Mean arterial blood pressure was reduced by ϳ30 mmHg in these mice (206) . The development of myogenic tone in response to intravascular pressure according to Bayliss (21) was abolished (206) . About 50% of the phenylephrine-induced resistance was lost in hindlimb perfusion experiments using this mouse line, indicating that Ca V 1.2␣ 1 is essential for the hormonal regulation of blood pressure and development of myogenic tone (206) . Rhythmic contractions of the small and large intestine of these mice were absent, and hormoneinduced contractions were diminished resulting in the observed reduced feces excretion (298) . These mice exhibited also a severely reduced micturition and bladder hypertrophy reminiscent to the symptoms of bladder outlet obstruction (299) . In addition, carbachol-induced contractions were diminished by ϳ90%, probably related to the loss of the PKCmediated regulation of the Ca V 1.2 channel (141, 299). Together, these studies strongly support the notion that the Ca V 1.2 channel is critical for the contractile function of various types of smooth muscle. ] i , which in turn influences luminal SR calcium and thus Ca 2ϩ sparks. Together, this study supports the notion that the Ca V 1.2 channel is not only critical for the contractile function but also mediates partially dilatory responses in smooth muscle.
The Ca V 1.2 channel has been implicated to function as metabotropic receptor in arterial smooth muscle (293) . In recent years, a new SR Ca 2ϩ release mechanism, depolarization-induced Ca 2ϩ release, has been postulated (66) . This pathway involves the Ca V 1.2 channel as membrane potential sensor that induces sarcoplasmic reticulum Ca 2ϩ release through G protein and phospholipase C activation followed by stimulation of the RhoA/RhoAassociated kinase pathway (84). The ion-conducting property of Ca V 1.2 is not used in this pathway. Deletion of Ca V 1.2␣ 1 gene in smooth muscle abolished this pathway (83) in line with its potentially functional relevance for hormone-induced SM contraction.
SM was shown to express mRNA for all Ca V ␤ subunits, but only two of the four Ca V ␤ subunits, namely, Ca V ␤ 2 and Ca V ␤ 3 , were clearly detected at the protein level (123, 137, 210). The role of Ca V ␤ 2 in smooth muscle could so far not be clarified in a mouse model, since global deletion of Ca V ␤ 2 was embryonic lethal because of cardiovascular dysfunction (302) . In contrast, Ca V ␤ 3 -deficient mice show no major cardiovascular phenotype in the absence of a high-salt diet (210) . In ileum SM cells, deletion of Ca V ␤ 3 has only subtle effects on L-type Ca 2ϩ current and was not required for spontaneous and potassium-induced contraction (123). However, it has been suggested that Ca V ␤ 3 might have a function beyond being a Ca 2ϩ channel subunit (23, 123) (see also sect. X).
XI. Ca V ␤ 2 AND Ca V ␤ 3 KNOCKOUT MICE
The cardiac Ca V 1.2␣ 1 subunit is associated with the Ca V ␤ 2 subunit (137, 181, 239), whereas the non-cardiac Ca V 1.2 ␣ 1 channel may be associated with the Ca V ␤ 2 and/or the Ca V ␤ 3 subunit (23, 123, 208, 209) . The Ca V ␤ 3 subunit like Ca V ␤ 1 , Ca V ␤ 2 , and Ca V ␤ 4 regulates also the function of the Ca V 1.3 channel and the neuronal Ca V 2.1 and Ca V 2.2 channel (207, 208, 216, 278) . Inactivation of the Ca V ␤ 2 gene leads to death at embryonic day 9.5 (13, 302). The same phenotype was observed after cardiomyocyte-specific Ca V ␤ 2 gene deletion in the embryo (302) . Cardiac-specific inactivation of the Ca V ␤ 2 gene in adult mice results in viable animals and a slightly reduced Ca V 1.2 current (Ϫ25%) (198) . Extracardiac inactivation of Ca V ␤ 2 affected the b-wave of the electroretinogram (13).
Inactivation of the Cav␤ 3 gene leads to viable animals with multiple phenotypes. Electrophysiological examinations showed a 30% reduction of the DHP-sensitive, L-type calcium current in aortic smooth muscle (210) . Ca V ␤ 3 -knockout mice showed a decreased sensitivity to DHPs, but normal blood pressure when they were raised on a normal diet. The Ca V ␤ 3 -knockout mice had an elevated blood pressure and heart hypertrophy in response to a high-salt diet (210) . In addition, Ca V ␤ 3 -knockout mice showed a more efficient glucose homeostasis compared with wild-type mice due to increased glucose-stimulated insulin secretion (23) and defective survival of naive CD8ϩ T lymphocytes (146). In sympathetic neurons, deletion of the Ca V ␤ 3 subunit reduced L-and N-type current and shifted the activation curve for the "reluctant" P/Q-type channel in hyperpolarizing direction (216) . The low expression of the N-type current in DRGs reduced chemically induced pain perception (208) .
XII. Ca V 1.2 AND SECRETION
Early studies identified Ca 2ϩ as intracellular coupling agent in the process of stimulus-secretion coupling (72) . Ca 2ϩ influx mediated by Ca V channels triggered the secretion of hormones from excitable endocrine cells, like the pancreatic ␤-cells (318) or the chromaffin cells from the adrenal gland (102). The contribution of single Ca V channel types to this Ca 2ϩ influx varies among species, with the Ca V 1.2 channel being the main mediator of Ca 2ϩ influx in ␤-cells and chromaffin cells from the mouse but not from humans (36, 99).
The predominant Ca V channel form expressed in murine pancreatic ␤-cells are the Ca V 1.2 and Ca V 1.3 channel (249) . ␤-Cell specific deletion of the Ca V 1.2 gene decreased fastphase insulin release (256), a phenotype reproduced by the mice expressing the DHP-insensitive Ca V 1.2 (264). In contrast, ␤-cells from Ca V 1.3 knockout mice showed almost unaltered insulin secretion, probably due to a compensatory overexpression of Ca V 1.2 channels (215) . The Ca V 1.3 channel has been associated with insulin release in humans (242) . Surprisingly, deletion of the Ca V ␤ 3 subunit had a strong effect on insulin secretion in mice. The lack of the Ca V ␤ 3 subunit facilitated insulin release, but only at high glucose, eventually because the Ca V ␤ 3 subunit inhibited inositol trisphosphatestimulated Ca 2ϩ release, an effect not mediated by the Ca V 1.2 channel (23). Interestingly, patients with the Timothy syndrome frequently showed hypoglycemia pointing to a possible increase in ␤-cell-mediated insulin secretion due to the enhanced Ca 2ϩ influx through the modified Ca V 1.2 channel that displays a reduced voltage-dependent inactivation (273) .
Similar to pancreatic ␤-cells, murine chromaffin cells from the adrenal gland express predominantly Ca V 1.2 and Ca V 1.3 channels (188) . Unfortunately, the effect of Ca V 1.2 gene inactivation in chromaffin cells could not be studied due to the lethality of the Ca V 1.2 knockout mice (260) . Inactivation of the Ca V 1.3 gene resulted in a reduced spontaneous firing rate in chromaffin cells, indicating a reduced catecholamine secretion (188) . Recently, mutations of the human Ca V 1.3 channel, which shifts the voltage dependence of activation to more hyperpolarized potentials, have been associated in adrenal glomerulosa cells with primary hyperaldosteronism leading to hypertension (254) .
Currents through Ca V 1.2 channels can be activated by cAMP/ PKA signaling cascade in both ␤-cells and chromaffin cells (155, 185) . Furthermore, cGMP decreased L-type current in chromaffin cells (185) . PKA and PKG modulated Ca V 1.2 and Ca V 1.3 currents in the same direction (185) . The molecular mechanism of this regulation has not been studied and may differ from the ␤-adrenergic regulation of the cardiac Ca V 1.2 channel.
XIII. CONCLUSION
The generation of various mouse lines with defects in genes of the Ca V 1.2 channel subunits has fundamentally extended the knowledge about the wide-ranged biological functions of Ca V 1.2 channel-dependent signaling processes and fruitfully complemented previous theories obtained solely by pharmacological tools. However, many potential functions have probably not yet been revealed. Limitations of the genemodifying approaches using mutant mice may involve the functional redundancy of Ca V 1.2 channel isoforms, induction of compensatory processes, or early embryonic lethality. To reduce these problems, researchers have started to generate mice with amino acid specific mutations and/or mutations related to specific Ca V 1.2 subunit isoforms. With the introduction of these probably more valuable mouse lines, it may be possible to get new interesting insights into the specific role of Ca V 1.2 channel subunits in vivo. 
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